Last update 09 Dec 2025

VXA-G2-4-NS

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
GII.4 oral vaccine tablet, Monovalent GII.4 tableted vaccine, Norovirus GII.4 vaccine
+ [3]
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Norovirus Infections
Originator Organization
Vaxart, Inc.Vaxart, Inc.
Active Organization-
Inactive Organization
Vaxart, Inc.Vaxart, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VXA-G2-4-NS
NCT05626803
/ CompletedPhase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single Dose, Dose-ranging Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccine Administered Orally to Healthy Volunteers Aged Greater Than or Equal to 18 Years and Less Than or Equal to 80 Years Old.
100 Clinical Results associated with VXA-G2-4-NS
Login to view more data
100 Translational Medicine associated with VXA-G2-4-NS
Login to view more data
100 Patents (Medical) associated with VXA-G2-4-NS
Login to view more data
100 Deals associated with VXA-G2-4-NS
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Norovirus InfectionsPhase 2
United States
Vaxart, Inc.Vaxart, Inc.
26 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05626803 (CTgov)
Phase 2
Norovirus Infections
135
(Bivalent GI.1/GII.4 Vaccine Medium Dose)
rzrzxaplew = muxtceishz eqhtnnoisw (erfkhrobgr, ojxjypsifx - bbsiytenbu)
View more
-
15 Apr 2025
Bivalent GI.1/GII.4 Vaccine
(Bivalent GI.1/GII.4 Vaccine High Dose)
rzrzxaplew = fpevakdshy eqhtnnoisw (erfkhrobgr, pxhvztuxdu - wtusnkmewy)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free